Ortec expanding cultured skin replacement burn study to five sites.
This article was originally published in The Gray Sheet
Executive Summary
ORTEC INTL.'S SKIN REPLACEMENT PRODUCT U.S. CLINICALS will be expanded to four additional burn centers in the next several months, according to the company. Patient enrollment in the 120-patient study of Ortec's Composite Cultured Skin (CCS) for treatment of severe burns already is under way at the initial site at Westchester Medical Center burn facility, Valhalla, New York. Negotiations for the remaining four trial sites are ongoing at burn centers in Connecticut, New Jersey and New York.